Welter ML - Search Results

1

Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.

Schüpbach M, Lohmann E, Anheim M, Lesage S, Czernecki V, Yaici S, Worbe Y, Charles P, Welter ML, Pollak P, Dürr A, Agid Y, Brice A. Schüpbach M, et al. Among authors: welter ml. Mov Disord. 2007 Jan;22(1):119-22. doi: 10.1002/mds.21178. Mov Disord. 2007. PMID: 17080443 Clinical Trial.

2

Clinical predictive factors of subthalamic stimulation in Parkinson's disease.

Welter ML, Houeto JL, Tezenas du Montcel S, Mesnage V, Bonnet AM, Pillon B, Arnulf I, Pidoux B, Dormont D, Cornu P, Agid Y. Welter ML, et al. Brain. 2002 Mar;125(Pt 3):575-83. doi: 10.1093/brain/awf050. Brain. 2002. PMID: 11872614

3

Parkinson's disease and sleepiness: an integral part of PD.

Arnulf I, Konofal E, Merino-Andreu M, Houeto JL, Mesnage V, Welter ML, Lacomblez L, Golmard JL, Derenne JP, Agid Y. Arnulf I, et al. Among authors: welter ml. Neurology. 2002 Apr 9;58(7):1019-24. doi: 10.1212/wnl.58.7.1019. Neurology. 2002. PMID: 11940685

4

Compulsions, Parkinson's disease, and stimulation.

Mallet L, Mesnage V, Houeto JL, Pelissolo A, Yelnik J, Behar C, Gargiulo M, Welter ML, Bonnet AM, Pillon B, Cornu P, Dormont D, Pidoux B, Allilaire JF, Agid Y. Mallet L, et al. Among authors: welter ml. Lancet. 2002 Oct 26;360(9342):1302-4. doi: 10.1016/S0140-6736(02)11339-0. Lancet. 2002. PMID: 12414208

5

Parkinson's disease is a neuropsychiatric disorder.

Agid Y, Arnulf I, Bejjani P, Bloch F, Bonnet AM, Damier P, Dubois B, François C, Houeto JL, Iacono D, Karachi C, Mesnage V, Messouak O, Vidailhet M, Welter ML, Yelnik J. Agid Y, et al. Among authors: welter ml. Adv Neurol. 2003;91:365-70. Adv Neurol. 2003. PMID: 12442695 Review. No abstract available.

6

Subthalamic stimulation in Parkinson disease: intraoperative predictive factors.

Houeto JL, Welter ML, Bejjani PB, Tezenas du Montcel S, Bonnet AM, Mesnage V, Navarro S, Pidoux B, Dormont D, Cornu P, Agid Y. Houeto JL, et al. Among authors: welter ml. Arch Neurol. 2003 May;60(5):690-4. doi: 10.1001/archneur.60.5.690. Arch Neurol. 2003. PMID: 12756132

7

Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients.

Welter ML, Houeto JL, Bonnet AM, Bejjani PB, Mesnage V, Dormont D, Navarro S, Cornu P, Agid Y, Pidoux B. Welter ML, et al. Arch Neurol. 2004 Jan;61(1):89-96. doi: 10.1001/archneur.61.1.89. Arch Neurol. 2004. PMID: 14732625

8

Subthalamic stimulation in Parkinson disease: with or without anesthesia?

Maltête D, Navarro S, Welter ML, Roche S, Bonnet AM, Houeto JL, Mesnage V, Pidoux B, Dormont D, Cornu P, Agid Y. Maltête D, et al. Among authors: welter ml. Arch Neurol. 2004 Mar;61(3):390-2. doi: 10.1001/archneur.61.3.390. Arch Neurol. 2004. PMID: 15023817

9

Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease.

Mesnage V, Houeto JL, Bonnet AM, Clavier I, Arnulf I, Cattelin F, Le Fur G, Damier P, Welter ML, Agid Y. Mesnage V, et al. Among authors: welter ml. Clin Neuropharmacol. 2004 May-Jun;27(3):108-10. doi: 10.1097/00002826-200405000-00003. Clin Neuropharmacol. 2004. PMID: 15190231 Clinical Trial.

10

Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14.

Stevanin G, Hahn V, Lohmann E, Bouslam N, Gouttard M, Soumphonphakdy C, Welter ML, Ollagnon-Roman E, Lemainque A, Ruberg M, Brice A, Durr A. Stevanin G, et al. Among authors: welter ml. Arch Neurol. 2004 Aug;61(8):1242-8. doi: 10.1001/archneur.61.8.1242. Arch Neurol. 2004. PMID: 15313841

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters